iiinova — where your digital self keeps evolving

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 11/05/2026

The @satviuct.bsky.social 2025 Annual Report has just been published. Read about our research progress, key clinical trial milestones, and contributions to the global TB control and vaccine development pipeline over the past year. Flipbook click here: lnkd.in/gniHMqqG PDF version: lnkd.in/giXiwniS

100

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 24/04/2026

🎉 Congratulations to Dr Vanessa Muwanga! Former @satviuct.bsky.social PhD student—now appointed Lecturer at Hanave University, teaching immunology, biomedical sciences & public health. Proud to see her take this next step and shape the next generation of health scientists! 👏🎓

010

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 24/04/2026

@satviuct.bsky.social Musvosvi,Nemes, Tameris, Mendelsohn, Fisher, Filander, Visagie, Africa, Jaxa, Mulenga, Veldsman, Hatherill and Scriba published a article "Optimisation & application of a T-cell antigen-specific activation assay as diagnostic & treatment-monitoring tool for TB. lnkd.in/dgR-B8Df

010

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 24/04/2026

🎉 Big congrats to Dr Vanessa Muwanga! Former @satviuct.bsky.social postdoc, now appointed Lecturer at Hanave University, teaching immunology, biomedical sciences & public health. We’re proud of you, Vanessa, and wish you every success! 👏🎓

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 24/04/2026

Vaccines have saved more than 150 million lives since 1974—not by chance, but because ordinary people chose to protect themselves, their children, and their communities. That’s six lives saved every minute, every day, for more than five decades. #VaccinesWork Your decision makes a difference.

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 24/04/2026

Professor Mark Hatherill, @satviuct.bsky.social has co-authored "A narrative review of the regional prospective observational research in TB international consortium: Sharing diverse data and specimens in the fight against tuberculosis". @cidjournal.bsky.social academic.oup.com/.../82/Suppl....

001

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 26/03/2026

Professor @tomscriba.bsky.social and Dr Monika Looney will be presenting at the World TB Day Symposium (27 March '26),organised by the @samrcza.bsky.social Centre for TB Research, housed at @suhealthsci.bsky.social Division of Molecular Biology & Human Genetics teams.microsoft.com/meet/3612608...

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 24/03/2026

Latest research: Optimisation & application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis. Authors: Associate Professor Munyaradzi Musvosvi, Professors Nemes & Scriba and SATVI colleagues. htps://pmc.ncbi.nlm.nih.gov/articles/PMC12969661/

011

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 23/03/2026

Professor Tom Scriba and Dr Monika Looney will be participating in the World TB Day Symposium organised by the @samrcza.bsky.social and Centre for TB Research and Division of Molecular Biology and Human Genetics at @suhealthsci.bsky.social. Date: Friday 27 March 2026.

010

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 23/03/2026

World TB Day is marked every year on 24 March to remind us how serious TB is and why we must work together to end it. The day also honours the discovery of the TB germ in 1882 — a breakthrough that made testing and treatment possible. @who.int; @uctidm-mu.bsky.social @stoptb.bsky.social

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 19/03/2026

Reminder about the upcoming seminar hosted by the South African Immunology Society, where Professors Mark Hatherill & Elisa Nemes will present the latest advances in TB vaccines and immunology taking place today 19 March 2026 at 13:00 to 14:00. To join scan the QR code or click on: lnkd.in/d39w8sPs

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 18/03/2026

Did you know how SATVI began? Our narrative history book shares the organisation’s story through the voices of the many people who shaped it since its founding. Click here to download. surl.li/bahidl

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 17/03/2026

In a Spotlight article, SATVI’s A/Prof Angelique Luabeya explains that the only TB vaccine is over a century old and offers limited protection. She notes that South Africans are leading trials of three new candidates, signalling a long‑awaited breakthrough. lnkd.in/dPV_XQRc

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 13/03/2026

World TB Day on 24 March raises awareness of TB, still causing 1.3 million deaths each year. Koch’s 1882 discovery made diagnosis possible, yet TB remains the world’s top infectious killer 144 years later. @stoptb.bsky.social @theaurum.bsky.social

010

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 13/03/2026

We have a vacancy for Data Scientist position within our dynamic clinical immunology group. Closing date: 19 March '26. To apply visit the UCT online job portal at: uct.ac.za/staff/genera...

011

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 13/03/2026

We have a vacancy for a Data Scientist within our dynamic TB research group based at the University of Cape Town. To apply, please visit the UCT online job portal at: uct.ac.za/staff/genera...

001

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 12/03/2026

Join us on 19 March 2026 (13:00–14:00) for a seminar hosted by the South African Immunology Society, where Professors Mark Hatherill and Elisa Nemes will present on Current Advances in TB Vaccines and Immunology. Don’t miss this important update in the TB research landscape. @uctidm-mu.bsky.social

100

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 05/03/2026

We have a vacancy for Data Scientist position within our dynamic clinical immunology group. To apply visit the UCT online job portal at: www.uct.ac.za

012

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 01/03/2026

Latest research: Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study appearing in the @plosmedicine.org journal. pubmed.ncbi.nlm.nih.gov/41678562/

164

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 01/03/2026

Latest research: Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study. Tanvir H, Clark RA, Sumner T, Horton KC, Prŷs-Jones TO, Bakker R, Rade K, Mave V, Hatherill M, Churchyard GJ, Houben RMGJ, White RG.

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 21/11/2025

Fri 21 Nov '25: Professor Tom Scriba will present an oral abstract titled: "Correlates of risk of TB disease following H56 administration to prevent disease recurrence " at the @UnionConference on Lung Health. 8:20-8:35 Venue: Auditorium 15 (Theatre). @stoptb.bsky.social @cidri-africa.bsky.social

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 20/11/2025

Fri 21 Nov '25: Professor Tom Scriba will present an oral abstract titled: "TBS10-15 Correlates of risk of TB disease following H56 administration to prevent disease recurrence " at the Union World Conference on Lung Health. @tomscriba.bsky.social

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 20/11/2025

Thursday 20 Nov '25: Dr Evans Muchiri to present oral abstract "Risk of progression to incident pulmonary TB among household contacts with abnormal chest X-rays in South Africa." at15:13 to 15:19 at the B2A venue.

010

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 20/11/2025

Dr Sarah Nyangu will present and oral abstract titled: "SOA10-607-20 Chest radiographic TB screening using human vs. artificial intelligence reads in asymptomatic adult household contacts in South Africa. Time: 14:19-14:25. Venue: B2A @Conf2025.theunion.org

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 20/11/2025

Doctor Simon Mendelsohn will present an oral abstract titled: TBS08-25 Universal screening for asymptomatic TB among adults with household exposure to a patient with pulmonary TB" at the Union World Conference on Lung Health. Time 9H28 in the Auditorium. conf2025.theunion.org

022

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 18/11/2025

Researchers from SATVI presenting oral abstracts at the 2025 Union World Conference on Lung Health.

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 17/11/2025

@satvi_uct Doctor Humphrey Mulenga will present and oral abstract on the risk of immunological sensitisation to M. tuberculosis and progression to incident TB disease in a high-burden setting.

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 17/11/2025

TB Science 2025-UnionConference on Lung Disease. Dr Virginie Rozot will present a oral abstract during the TB Science 2025 on the sidelines of the @UnionConference on Tuesday 18 November between 14h40 and 16H15. shorturl.at/xVuCU

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 17/11/2025

Doctor Virginie Rozot will present findings from a study into the relationship between mycobacterial synthetic activity and host immune systems in people with clinically active disease & those with no clinical signs from M.tb detected in lymph nodes. tinyurl.com/4shpx5cy

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 17/11/2025

Professor @tomscriba.bsky.social will present an oral abstract on the immunological signatures of asymptomatic TB at the Union Conference on Lunge health on Wednesday 19 November 2025. conf2025.theunion.org/programme/

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 29/10/2025

SATVI’s Tatenda L Bvudzijena will be presenting a poster at the HIP Research Dayon Thursday 30 October 2025.

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 29/10/2025

SATVI’s Ahlisha Chetty will be presenting a poster at the HIP Research Day on Thursday 30 October 2025.

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 29/10/2025

SATVI is inviting applications for a postdoctoral fellowship within our dynamic clinical immunology group to conduct immunology research on TB vaccines and immunopathogenesis in humans. Closing date: 31 October. @uctidm-mu.bsky.social @who.int lnkd.in/d7h4FNVg

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 16/10/2025

The 2024 SATVI Annual Report is now available. Flipbook: online.fliphtml5.com/bqqif/qdae/ PDF download: www.dropbox.com/scl/fi/ab653...

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 31/07/2025

TB is the leading cause of disease of people living with HIV. TB can only be be beaten through the development of new vaccines to prevent TB infection and disease, quicker diagnostic tools and shorter, more effective drugs to cure. @stoptb.bsky.social; @cidri-africa.bsky.social; @who.int;

022

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 09/07/2025

Dr Anele Gela, Research Officer at @satviuct.bsky.social‬ discusses the work that he does at the SATVI on host determinants of protective immunity against Mycobacterium tuberculosis. open.spotify.com/episode/7nD5...

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 08/07/2025

@satviuct.bsky.social‬ Dr Simon Mendelsohn will be presenting a seminar titled "Beyond the Cough: Non-Sputum Strategies for TB Diagnosis" on 23 July 2025 at a UCT Institute of Infectious diseases and Molecular Medicine; INPERSON SEMINAR. @stoptb.bsky.social; idm.uct.ac.za/events/idm-c...

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 08/07/2025

Bit of good news. NIH has lifted hold on payments for existing research grants to South Africa, in HIV & other infectious diseases. Although no new awards can be made, existing subawards with clinical research can continue under the new “supplement” plan. www.science.org/content/arti...

science.org

NIH restores grants to South Africa scientists, adds funding option for other halted foreign projects

A policy tweak to the ban on foreign “subawards” should allow clinical trials worldwide to continue

012

Reposted by South African Tuberculosis Vaccine Initiative (SATVI)

Apoorva Mandavilli @apoorvanyt.bsky.social · 07/07/2025

BREAKING: Six leading medical organizations filed a lawsuit on Monday against Robert F. Kennedy Jr., the health secretary, and the health dept, charging that recent decisions limiting access to vaccines were unscientific and harmful to the public. (Gift link) www.nytimes.com/2025/07/07/h...

nytimes.com

Medical Societies Sue Kennedy and H.H.S. Over Vaccine Advice

220112053405

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 08/07/2025

What sad is that there is a safe, efficacious vaccine which is administered in drop form and which prevents measles. Two doses of a combined vaccine called Measles, Mump and Rubella (MMR) provides the best protection against measles..

000

Reposted by South African Tuberculosis Vaccine Initiative (SATVI)

The Washington Post @washingtonpost.com · 07/07/2025

The United States has recorded its highest annual measles cases in 33 years. The milestone marks a public health reversal in defeating a highly contagious, vaccine-preventable disease as the anti-vaccine movement gains strength.

washingtonpost.com

U.S. measles cases reach 33-year record high as outbreaks spread

Johns Hopkins University data reflects the public health reversal in defeating the vaccine-preventable disease since measles was officially eliminated from the U.S. in 2000.

68872583105

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 03/07/2025

The Validate Network reports on a paper appearing in the @biomedcentral.bsky.social on the delivery of new tuberculosis vaccines to people living with HIV, when to vaccinate? bmcinfectdis.biomedcentral.com/articles/10....

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 17/06/2025

Professor Mark Hatherill, Director SATVI will present a seminar titled: "A century of TB vaccine development" on Wednesday 18 June 2024 at the UCT Institute of Infectious Diseases and Molecular Medicine @uctidm-mu.bsky.social @tomscriba.bsky.social Attendance in person. Register at lnkd.in/dQGZHKbk

000

South African Tuberculosis Vaccine Initiative (SATVI) @satviuct.bsky.social · 09/06/2025

Findings from the IAVI A-050 study, published in @lancetgh.bsky.social demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG. www.thelancet.com/journals/lan...

011